Jacques Rouanet

Publications

Article dans une revue (10)

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients’ Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC) Charlée Nardin,Aymeric Hennemann,Kadiatou Diallo,Elisa Funck-Brentano,Ève Puzenatet al. Cancers, 2023, 15 (14), pp.3564. ⟨10.3390/cancers15143564⟩ Article dans une revue hal-04229565v1
Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study David Balayssac,Bruno Pereira,Juliette Desmard,Hugo Viers,Carole Barillonet al. European Journal of Cancer Care, 2023, 2023, pp.1 - 9. ⟨10.1155/2023/7746349⟩ Article dans une revue hal-04213488v1
Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT) Emilie Thivat,Marion Chanchou,Sylvain Mathieu,Sophie Levesque,Tommy Billouxet al. Frontiers in Medicine, 2022, 9, pp.993151. ⟨10.3389/fmed.2022.993151⟩ Article dans une revue hal-03854911v1
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol Emilie Thivat,Jacques Rouanet,Philippe Auzeloux,Nicolas Sas,Elodie Joubertonet al. BMC Cancer, 2022, 22 (1), pp.417. ⟨10.1186/s12885-022-09495-3⟩ Article dans une revue hal-03646672v1
Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses Jacques Rouanet,Ines Joulie,Celine Lambert,Michel d'Incan Acta Dermato-Venereologica, 2022, 102, ⟨10.2340/actadv.v102.718⟩ Article dans une revue hal-03868353v1
Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification Gulnur Ungan,Anne-Flore Lavandier,Jacques Rouanet,Constance Hordonneau,Benoit Chauveauet al. International Journal of Computer Assisted Radiology and Surgery, 2022, 17 (10), pp.1867-1877. ⟨10.1007/s11548-022-02662-8⟩ Article dans une revue hal-03868135v1
The Role of Surgery After Remission of Nonsystemic Extensive Periorbital Basal Cell Carcinoma Treated by Vismodegib: A Systematic Review Delphine Peillex,Léa Passemard,Benoit Magnin,Jacques Rouanet,Nathalie Pham Dang Dermatologic Surgery, 2022, 48 (9), pp.905-911. ⟨10.1097/DSS.0000000000003508⟩ Article dans une revue hal-03868041v1
New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination. Solène Delorme,Maud Privat,Nicolas Sonnier,Jacques Rouanet,Tiffany Witkowskiet al. American Journal of Cancer Research, 2021, 11 (4), pp.1600-1615 Article dans une revue hal-03345236v1
Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma Hussein Akil,Mercedes Quintana,Jérémy H Raymond,Tommy Billoux,Valentin Benboubkeret al. Cancers, 2021, 13 (6), pp.1421. ⟨10.3390/cancers13061421⟩ Article dans une revue hal-03437826v1
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy Léa Dousset,Florence Poizeau,Caroline Robert,Sandrine Mansard,Laurent Mortieret al. JCO precision oncology, 2021, 5 (5), pp.PO.21.00084. ⟨10.1200/PO.21.00084⟩ Article dans une revue inserm-03525310v1